WestEnd Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-34
Closed -$2.9K 414
2026
Q1
$2.9K Hold
34
﹤0.01% 130
2025
Q4
$2.69K Hold
34
﹤0.01% 136
2025
Q3
$2.72K Buy
34
+5
+17% +$427 ﹤0.01% 135
2025
Q2
$2.64K Sell
29
-2
-6% -$183 ﹤0.01% 134
2025
Q1
$2.9K Buy
31
+21
+210% +$1.88K ﹤0.01% 130
2024
Q4
$909 Buy
10
+1
+11% +$95 ﹤0.01% 139
2024
Q3
$934 Buy
9
+2
+29% +$204 ﹤0.01% 131
2024
Q2
$679 Hold
7
﹤0.01% 142
2024
Q1
$630 Sell
7
-6
-46% -$508 ﹤0.01% 138
2023
Q4
$1.04K Hold
13
﹤0.01% 114
2023
Q3
$924 Buy
+13
New +$972 ﹤0.01% 116
2023
Q1
Sell
-10
Closed -$744 114
2022
Q4
$788 Buy
10
+2
+25% +$150 ﹤0.01% 112
2022
Q3
$1K Buy
+8
New +$627 ﹤0.01% 102

Other funds holding CL

WestEnd Advisors's CL Position: Q2 2026 in Review

WestEnd Advisors sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 34 shares — an estimated $2.9K sold.

WestEnd Advisors first reported a position in CL in Q3 2022 and held it in 13 quarters. The position peaked at $2.9K in Q1 2025. 2,015 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • WestEnd Advisors reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
  • WestEnd Advisors sold 34 Colgate-Palmolive shares in Q2 2026, an estimated $2.9K.
  • WestEnd Advisors first reported a position in Colgate-Palmolive in Q3 2022 and held it in 13 quarters.
  • WestEnd Advisors's Colgate-Palmolive position peaked at $2.9K in Q1 2025.
  • 2,015 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.